Liu, Haiyin

Prescription Opioid Use among Adults with Mental Health Disorders in the United States

Davis, M. A., Lin, L. A., Liu, H., & Sites, B. D. (2017) · The Journal of the American Board of Family Medicine

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 270

Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial

Wexler, D. J., de Boer, I. H., Ghosh, A., Younes, N., Bebu, I., Inzucchi, S. E., McGill, J. B., Mudaliar, S., Schade, D., Steffes, M. W., et al. (2023) · JAMA Internal Medicine

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 39

Efficient mRNA delivery to resting T cells to reverse HIV latency

Cevaal, P. M., Kan, S., Fisher, B. M., Moso, M. A., Tan, A., Liu, H., Ali, A., Tanaka, K., Shepherd, R. A., Kim, Y., et al. (2025) · Nature Communications

RNA Interference and Gene DeliveryHIV Research and Treatment

Cited by 38

Major histocompatibility class II in murine antigen presenting cells is modified with a branched K63 and K11-linked ubiquitin chain

Liu, H., Francis, L., Dagley, L. F., Cobbold, S. A., Webb, A. I., Komander, D., Villadangos, J. A., & Mintern, J. D. (2025) · Scientific Reports

Ubiquitin and proteasome pathwaysImmunotherapy and Immune Responses

Cited by 2

Major histocompatibility class II in murine antigen presenting cells is modified with a branched K63 and K11-linked ubiquitin chain

Liu, H., Francis, L., Dagley, L. F., Cobbold, S. A., Webb, A. I., Komander, D., Villadangos, J. A., & Mintern, J. D. (2025) · Scientific Reports

Ubiquitin and proteasome pathwaysImmunotherapy and Immune Responses

Cited by 2